Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. Its product range includes Chinese medicines, chemical drugs, biological and health products, and medical appliances covering the area of cardio-cerebrovascular, pediatric, anti-flu and respiratory, anti-infection, detoxification, urological agents, and others. The company offers its health products under the Herb Valley and Tuokang brands. It also engages in the sale and wholesale of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicines; provision of Chinese medical services; and trading of agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.
Tianda Pharmaceuticals Dividend Announcement
• Tianda Pharmaceuticals announced a annually dividend of HK$0.00 per ordinary share which will be made payable on 2024-06-28. Ex dividend date: 2024-06-13
• Tianda Pharmaceuticals annual dividend for 2024 was HK$0.00
• Tianda Pharmaceuticals annual dividend for 2023 was HK$0.00
• Tianda Pharmaceuticals's trailing twelve-month (TTM) dividend yield is 1.41%
• Tianda Pharmaceuticals's payout ratio for the trailing twelve months (TTM) is -13.97%
• Tianda Pharmaceuticals's dividend growth over the last five years (2018-2023) was -5.77% year
Tianda Pharmaceuticals Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-06-13 | HK$0.00 | annually | 2024-06-28 |
2023-06-29 | HK$0.00 | annually | 2023-07-14 |
2022-09-02 | HK$0.01 | annually | 2022-09-16 |
2022-08-29 | HK$0.01 | annually | |
2021-09-03 | HK$0.00 | annually | 2021-09-23 |
2020-09-03 | HK$0.00 | annually | 2020-09-23 |
2019-09-02 | HK$0.00 | annually | 2019-09-20 |
2018-08-31 | HK$0.00 | annually | 2018-09-21 |
2017-09-01 | HK$0.01 | annually | 2017-09-22 |
2016-08-25 | HK$0.00 | annually | |
2014-09-08 | HK$0.00 | annually | |
2013-09-17 | HK$0.00 | annually | |
2012-09-06 | HK$0.00 | annually |
Tianda Pharmaceuticals Dividend per year
Tianda Pharmaceuticals Dividend growth
Tianda Pharmaceuticals Dividend Yield
Tianda Pharmaceuticals current trailing twelve-month (TTM) dividend yield is 1.41%. Interested in purchasing Tianda Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:
Tianda Pharmaceuticals Financial Ratios
Tianda Pharmaceuticals Dividend FAQ
Other factors to consider when evaluating Tianda Pharmaceuticals as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Tianda Pharmaceuticals stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Tianda Pharmaceuticals's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Tianda Pharmaceuticals publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Tianda Pharmaceuticals distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Tianda Pharmaceuticals are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Tianda Pharmaceuticals sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Tianda Pharmaceuticals distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Tianda Pharmaceuticals declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Tianda Pharmaceuticals's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Tianda Pharmaceuticals's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.